Summit Therapeutics (SMMT) Other Operating Expenses (2016 - 2024)
Historic Other Operating Expenses for Summit Therapeutics (SMMT) over the last 6 years, with Q4 2024 value amounting to $205000.0.
- Summit Therapeutics' Other Operating Expenses rose 1452.51% to $205000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $205000.0, marking a year-over-year decrease of 9862.62%. This contributed to the annual value of $313000.0 for FY2024, which is 6873.13% down from last year.
- Latest data reveals that Summit Therapeutics reported Other Operating Expenses of $205000.0 as of Q4 2024, which was up 1452.51% from -$264000.0 recorded in Q3 2024.
- Over the past 5 years, Summit Therapeutics' Other Operating Expenses peaked at $15.0 million during Q2 2024, and registered a low of -$264000.0 during Q3 2024.
- Its 3-year average for Other Operating Expenses is $3.1 million, with a median of $265000.0 in 2023.
- Examining YoY changes over the last 5 years, Summit Therapeutics' Other Operating Expenses showed a top increase of 1452.51% in 2024 and a maximum decrease of 19962.26% in 2024.
- Quarter analysis of 3 years shows Summit Therapeutics' Other Operating Expenses stood at $1.1 million in 2022, then tumbled by 84.2% to $179000.0 in 2023, then increased by 14.53% to $205000.0 in 2024.
- Its Other Operating Expenses was $205000.0 in Q4 2024, compared to -$264000.0 in Q3 2024 and $15.0 million in Q2 2024.